150 related articles for article (PubMed ID: 9401180)
1. Patch testing in the detection of cutaneous reactions caused by carbamazepine.
Liao HT; Hung KL; Wang CF; Chen WC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(5):365-9. PubMed ID: 9401180
[TBL] [Abstract][Full Text] [Related]
2. Patch testing in cutaneous reactions caused by carbamazepine.
Alanko K
Contact Dermatitis; 1993 Nov; 29(5):254-7. PubMed ID: 8112065
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
4. [Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs].
Ben Mahmoud L; Bahloul N; Ghozzi H; Kammoun B; Hakim A; Sahnoun Z; Kammoun S; Zeghal K
Therapie; 2017 Oct; 72(5):539-545. PubMed ID: 28416298
[TBL] [Abstract][Full Text] [Related]
5. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
Barbaud A
Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of drug rashes due to antiepileptics.
Sharma VK; Vatve M; Sawhney IM; Kumar B
J Assoc Physicians India; 1998 Jul; 46(7):595-7. PubMed ID: 12152838
[TBL] [Abstract][Full Text] [Related]
7. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.
Lin YT; Chang YC; Hui RC; Yang CH; Ho HC; Hung SI; Chung WH
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):356-64. PubMed ID: 22211830
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of skin tests to prove drug hypersensitivity.
Lammintausta K; Kortekangas-Savolainen O
Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
[TBL] [Abstract][Full Text] [Related]
9. Utility of patch testing for patients with drug eruption.
Ohtoshi S; Kitami Y; Sueki H; Nakada T
Clin Exp Dermatol; 2014 Apr; 39(3):279-83. PubMed ID: 24635061
[TBL] [Abstract][Full Text] [Related]
10. Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl.
Buyuktiryaki AB; Bezirganoglu H; Sahiner UM; Yavuz ST; Tuncer A; Kara A; Sackesen C
Australas J Dermatol; 2012 Nov; 53(4):274-7. PubMed ID: 22524313
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers.
Gonzalo Garijo MA; Pérez Calderón R; de Argila Fernández-Durán D; Rangel Mayoral JF
Allergol Immunopathol (Madr); 2005; 33(4):238-40. PubMed ID: 16045866
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine induced erythroderma with systemic lymphadenopathy.
Okuyama R; Ichinohasama R; Tagami H
J Dermatol; 1996 Jul; 23(7):489-94. PubMed ID: 8772031
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant drug hypersensitivity.
Galindo PA; Borja J; Gómez E; Mur P; Gudín M; García R; Encinas C; Romero G; Garrido JA; Cortina P; Feo F
J Investig Allergol Clin Immunol; 2002; 12(4):299-304. PubMed ID: 12926190
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
15. Drug eruptions: the value of oral rechallenge test and patch test.
Puavilai S; Chunharas A; Kamtavee S; Pongwiriyapanich S
J Med Assoc Thai; 2002 Feb; 85(2):263-9. PubMed ID: 12081129
[TBL] [Abstract][Full Text] [Related]
16. Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine.
Lee AY; Choi J; Chey WY
Contact Dermatitis; 2003 Mar; 48(3):137-9. PubMed ID: 12755726
[TBL] [Abstract][Full Text] [Related]
17. Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives.
Chen W; Hsieh FS
Eur J Dermatol; 2002; 12(5):488-90. PubMed ID: 12370143
[TBL] [Abstract][Full Text] [Related]
18. [Skin and hair].
Briner VA
Schweiz Med Wochenschr; 1996 Apr; 126(14):549-58. PubMed ID: 8668968
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous adverse reaction to carbamazepine: unusual presentation].
Duarte AF; Baudrier T; Mota A; Azevedo F
Acta Med Port; 2010; 23(2):267-72. PubMed ID: 20470476
[TBL] [Abstract][Full Text] [Related]
20. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
Hassoun-Kheir N; Bergman R; Weltfriend S
Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
